Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor
- 30 April 1997
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 74 (1-2) , 85-94
- https://doi.org/10.1016/s0165-5728(96)00210-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Relaxed Specificity of Matrix Metalloproteinases (MMPS) and TIMP Insensitivity of Tumor Necrosis Factor-α (TNF-α) Production Suggest the Major TNF-α Converting Enzyme Is Not an MMPBiochemical and Biophysical Research Communications, 1996
- Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic windowBrain Research, 1995
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- Human t lymphocytes express a member of the matrix metalloproteinase gene familyArthritis & Rheumatism, 1994
- Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic ProteinBiochemical and Biophysical Research Communications, 1993
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in ratsJournal of Neuroimmunology, 1991
- Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.The Journal of Experimental Medicine, 1987
- Proteolysis and myelin breakdown: a review of recent histochemical and biochemical studiesJournal of Molecular Histology, 1969